An act to amend the Controlled Drugs and Substances Act and the Food and Drugs Act
This enactment amends the Controlled Drugs and Substances Act and the Food and Drugs Act to allow psilocin and psilocybin to be used for medical treatment in accordance with the Narcotic Control Regulations. It also provides for the automatic approval of requests for priority review for certain new drugs.
House First Reading
Canada Gazette activity is tracked from January 2025 onward — regulations made before 2025 are not shown.
Canada Gazette activity is tracked from January 2025 onward — regulations made before 2025 are not shown.